Neogen Debt to Equity Ratio 2010-2025 | NEOG
Current and historical debt to equity ratio values for Neogen (NEOG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Neogen debt/equity for the three months ending February 28, 2025 was 0.33.
| Neogen Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-02-28 | $1.38B | $2.66B | 0.52 |
| 2024-11-30 | $1.39B | $2.67B | 0.52 |
| 2024-08-31 | $1.37B | $3.14B | 0.44 |
| 2024-05-31 | $1.41B | $3.14B | 0.45 |
| 2024-02-29 | $1.44B | $3.15B | 0.46 |
| 2023-11-30 | $1.46B | $3.15B | 0.46 |
| 2023-08-31 | $1.42B | $3.15B | 0.45 |
| 2023-05-31 | $1.42B | $3.13B | 0.45 |
| 2023-02-28 | $1.38B | $3.13B | 0.44 |
| 2022-11-30 | $1.46B | $3.11B | 0.47 |
| 2022-08-31 | $0.09B | $0.88B | 0.11 |
| 2022-05-31 | $0.11B | $0.89B | 0.12 |
| 2022-02-28 | $0.11B | $0.88B | 0.12 |
| 2021-11-30 | $0.10B | $0.87B | 0.12 |
| 2021-08-31 | $0.08B | $0.86B | 0.09 |
| 2021-05-31 | $0.08B | $0.84B | 0.10 |
| 2021-02-28 | $0.07B | $0.81B | 0.09 |
| 2020-11-30 | $0.07B | $0.78B | 0.09 |
| 2020-08-31 | $0.07B | $0.75B | 0.09 |
| 2020-05-31 | $0.07B | $0.73B | 0.10 |
| 2020-02-29 | $0.06B | $0.71B | 0.09 |
| 2019-11-30 | $0.06B | $0.69B | 0.09 |
| 2019-08-31 | $0.06B | $0.66B | 0.09 |
| 2019-05-31 | $0.06B | $0.64B | 0.09 |
| 2019-02-28 | $0.05B | $0.62B | 0.09 |
| 2018-11-30 | $0.06B | $0.60B | 0.10 |
| 2018-08-31 | $0.06B | $0.58B | 0.10 |
| 2018-05-31 | $0.06B | $0.56B | 0.10 |
| 2018-02-28 | $0.05B | $0.54B | 0.10 |
| 2017-11-30 | $0.06B | $0.52B | 0.12 |
| 2017-08-31 | $0.06B | $0.49B | 0.12 |
| 2017-05-31 | $0.06B | $0.47B | 0.12 |
| 2017-02-28 | $0.06B | $0.45B | 0.12 |
| 2016-11-30 | $0.05B | $0.44B | 0.12 |
| 2016-08-31 | $0.05B | $0.42B | 0.12 |
| 2016-05-31 | $0.05B | $0.40B | 0.11 |
| 2016-02-29 | $0.04B | $0.39B | 0.11 |
| 2015-11-30 | $0.05B | $0.38B | 0.13 |
| 2015-08-31 | $0.04B | $0.37B | 0.12 |
| 2015-05-31 | $0.04B | $0.35B | 0.12 |
| 2015-02-28 | $0.04B | $0.34B | 0.12 |
| 2014-11-30 | $0.04B | $0.33B | 0.12 |
| 2014-08-31 | $0.04B | $0.32B | 0.12 |
| 2014-05-31 | $0.04B | $0.31B | 0.13 |
| 2014-02-28 | $0.04B | $0.29B | 0.14 |
| 2013-11-30 | $0.04B | $0.28B | 0.13 |
| 2013-08-31 | $0.04B | $0.27B | 0.14 |
| 2013-05-31 | $0.03B | $0.26B | 0.13 |
| 2013-02-28 | $0.04B | $0.25B | 0.14 |
| 2012-11-30 | $0.03B | $0.24B | 0.13 |
| 2012-08-31 | $0.03B | $0.23B | 0.14 |
| 2012-05-31 | $0.03B | $0.22B | 0.15 |
| 2012-02-29 | $0.03B | $0.21B | 0.15 |
| 2011-11-30 | $0.03B | $0.20B | 0.15 |
| 2011-08-31 | $0.03B | $0.20B | 0.16 |
| 2011-05-31 | $0.03B | $0.19B | 0.16 |
| 2011-02-28 | $0.03B | $0.18B | 0.17 |
| 2010-11-30 | $0.03B | $0.17B | 0.18 |
| 2010-08-31 | $0.03B | $0.16B | 0.19 |
| 2010-05-31 | $0.03B | $0.15B | 0.18 |
| 2010-02-28 | $0.02B | $0.15B | 0.13 |
| 2009-11-30 | $0.02B | $0.14B | 0.14 |
| 2009-08-31 | $0.02B | $0.14B | 0.12 |
| 2009-05-31 | $0.01B | $0.13B | 0.11 |
| 2009-02-28 | $0.02B | $0.13B | 0.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.198B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.094B | 27.91 |
| Boston Scientific (BSX) | United States | $148.004B | 37.05 |
| Stryker (SYK) | United States | $145.912B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $130.051B | 0.00 |
| Medtronic (MDT) | Ireland | $112.158B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.407B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.971B | 27.90 |
| ResMed (RMD) | United States | $36.801B | 27.64 |
| Agilent Technologies (A) | United States | $33.162B | 21.62 |
| GE HealthCare Technologies (GEHC) | United States | $32.817B | 15.58 |
| Terumo (TRUMY) | Japan | $26.665B | 34.63 |
| Koninklijke Philips (PHG) | Netherlands | $22.070B | 15.86 |
| Insulet (PODD) | United States | $21.511B | 84.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.366B | 11.80 |
| Baxter (BAX) | United States | $15.831B | 11.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.086B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.138B | 21.36 |
| Lantheus Holdings (LNTH) | United States | $5.758B | 14.52 |
| Prestige Consumer Healthcare (PBH) | United States | $4.234B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.598B | 9.12 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.442B | 15.68 |
| ICU Medical (ICUI) | United States | $3.353B | 24.73 |
| Envista Holdings (NVST) | United States | $3.224B | 26.79 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.043B | 14.05 |
| LeMaitre Vascular (LMAT) | United States | $1.883B | 42.08 |
| AtriCure (ATRC) | United States | $1.692B | 0.00 |
| Acuren (TIC) | United States | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.132B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.087B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.082B | 24.33 |
| Phibro Animal Health (PAHC) | United States | $0.982B | 12.55 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Capricor Therapeutics (CAPR) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.581B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.413B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.91 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.327B | 58.20 |
| Canopy Growth (CGC) | Canada | $0.298B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Cresco Labs (CRLBF) | United States | $0.263B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.89 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.05 |
| Quanterix (QTRX) | United States | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.08 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.184B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.40 |
| Vireo Growth (VREOF) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.43 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |